Pre Transplantation Melanoma

Melanoma incidence is increase in global population and number of transplantation also. However immunosuppressor increase recurrence risk of melanoma.

There are more and more cases of eligible patients to transplant with an antecedent of melanoma. There is no guideline yet.

Main objective is survival time without melanoma recurrence in this population to do guideline of time limit or not between melanoma and transplantation by stage.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Malignant Melanoma Melanoma Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Germ Cell and Embryonal Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Nevi and Melanomas Skin Diseases Skin Neoplasms Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

service de dermatologie - hopital Edouard Herriot

Lyon, Rhone, 69003, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient with an antecedent of melanoma before transplantation
Not opposite to participate

Exclusion criteria

Under the age of 18
patient under Guardianship
patient not affiliated with a health system

Treatment and study plan

patient with melanoma pre transplantation

Other

survival time without melanoma recurrence

Primary outcomes

survival time without melanoma recurrence

Time frame: at enrollment

Delay in recurrence-free survival since diagnosis and since transplantation

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study

Acronym: MPG

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Jan 3, 2020
Registry last updated: Dec 10, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed